共 50 条
- [33] What Makes Some Mitigation Measures and Programs "Creative"? (And Where Does That Leave the Rest of Them?) ADVANCES IN ARCHAEOLOGICAL PRACTICE, 2020, 8 (03): : 220 - 224
- [34] Futile MITRA-FR and a positive COAPT trial: Where does the evidence leave the clinicians? IJC HEART & VASCULATURE, 2019, 22 : 18 - 19
- [38] Industry integration: Where will it leave us ADVANCES IN PORK PRODUCTION, VOL 11, 2000, : 59 - 66